This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...